Another Billion dollar deal for an Israeli company

The life science / medical device company Valtech Cardio, that develops innovative surgical and transcatheter valve repair and replacement devices for the treatment of the most prevalent heart valve diseases – mitral valve regurgitation (MR) and tricuspid valve regurgitation (TR), is being bought by American HeartWare International in a deal which is estimated at around one billion Dollars: http://www.prnewswire.com/news-releases/heartware-international-enters-into-definitive-agreement-to-acquire-valtech-cardio-ltd-300136319.html

2015-09-07T08:43:07+00:00September 7th, 2015|export, General, Israel, Technology|0 Comments